- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Maxum's revenues improved in 1995
Imaging services firm Maxum Health reported its last year of financialresults as a separate company before it is merged with AmericanHealth Services (SCAN 3/13/96). The Dallas company reported higherrevenues for 1995 (end-December), due in part to
Imaging services firm Maxum Health reported its last year of financialresults as a separate company before it is merged with AmericanHealth Services (SCAN 3/13/96). The Dallas company reported higherrevenues for 1995 (end-December), due in part to several imagingcenter acquisitions made last year, although the company fellback into the red after a profitable 1994.
For the year, Maxum had revenues of $50.6 million, up 10% overthe $45.9 million in sales reported in 1994. The company posteda net loss of $4.3 million for the year, compared with a $4.2million profit in 1994.
Maxum's operating loss narrowed, however, to $1.2 million in1995 from $2.8 million the year before, when Maxum recorded aone-time gain of $3.3 million on extinguishment of debt and a$4.8 million gain on the sale of its lithotripsy business. Maxumalso took a $1.5 million charge last year to settle securitieslitigation filed in 1993.
New Study Assesses Long-Term Outcomes of PSMA PET Use in PCa Recurrence Cases
October 24th 2024For patients with biochemical recurrence of prostate cancer, PSMA PET imaging may facilitate a 12.8 percent lower incidence of prostate cancer mortality in contrast to the combination of CT and bone scan, according to long-term outcome estimates from a new decision-analytic modeling study.
Can Diffusion MRI Predict Patient Response to Neoadjuvant Chemotherapy for Breast Cancer?
October 23rd 2024A model emphasizing time-dependent diffusion MRI was 15 percent more effective than apparent diffusion coefficient (ADC) measurements at predicting pathologic complete response to neoadjuvant chemotherapy for women with breast cancer, according to new research.
